FDA target action date (PDUFA date) for bezuclastinib in combination with sunitinib for patients with GIST scheduled. High importance estimated due to potential for significant market expansion upon approval.
Akros SCHK HK-U.S. High Beta Factor Index
High-beta exposure across Hong Kong Southbound leaders and U.S. equities.
Recent events
Next earnings release for Q2 2026 is scheduled for August 20, 2026. The company provided Q2 EPS guidance of $1.85-$1.93, and analysts forecast EPS around $1.90. This major earnings catalyst is estimated to have a >10% price impact scheduled.
Hut 8 is expected to release its Q2 2026 earnings results on August 6, 2026, as analysts forecast based on historical reporting patterns; a 5% price impact is estimated based on historical earnings volatility forecasted.
Q2 2026 earnings release is scheduled for August 5, 2026, before the market opens; analysts forecast an EPS of around $0.31. Medium importance based on previous earnings volatility was expected.
Q2 2026 earnings release and conference call scheduled. Medium importance estimated as earnings typically drive moderate volatility.
Second quarter 2026 financial results to be released after market close on August 3, 2026; estimated price impact is Low (1-5%) as the date announcement is a routine administrative event, scheduled.
High importance is estimated due to expected market volatility for the Q4 2026 earnings release (quarter ending May 31, 2026) scheduled for 2026-07-29; analysts forecast an EPS of -$0.20 to -$0.24, scheduled.
Q2 2026 earnings release scheduled; low impact expected for routine scheduled announcement.
Q2 2026 earnings results and conference call for July 27, 2026, with high importance estimated due to the potential for price impact exceeding 10% based on results and guidance, scheduled.
Q2 2026 earnings release and conference call, with a moderate market impact justifying a Medium importance rating, scheduled.
Ultra Clean to appoint Michael Keogh as Chief Financial Officer, effective July 8, 2026, following the retirement of Sheri Savage; estimated price impact is Low (1-5%) as executive transitions are generally stable, scheduled.